Biocompatible, biomimetic ampholyte materials

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9567357
SERIAL NO

13529708

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

New ampholyte biomaterial compounds containing ampholyte moieties are synthesized and integrated into polymeric assemblies to provide hydrophilic polymers exhibiting improved biocompatibility, haemocompatibility, hydrophilicity non-thrombogenicity, anti-bacterial ability, and mechanical strength, as well as suitability as a drug delivery platform.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOINTERACTIONS LTDSHINFIELD READING BERKSHIRE RG2 9LH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
McKendrick, John E Reading, GB 3 8
Onis, Simon J Reading, GB 3 8
Raisin-Dadre, Fanny Reading, GB 1 4
Rhodes, Alan Reading, GB 14 235
Sandhu, Shivpal S Buckinghamshire, GB 13 380

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 14, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00